Patent details

Basic Information

Publication number:

EP3480209

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP181673708

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

EXPRESSION SYSTEM

French Title of Invention:

SYSTÈME D'EXPRESSION

German Title of Invention:

EXPRESSIONSSYSTEM

SPC Number:

Dates

Filing date:

07/10/2010

Grant date:

29/11/2023

EP Publication Date:

08/05/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/11/2023

EP B1 Publication Date:

29/11/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

07/10/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/11/2023

 

 

Name:

GlaxoSmithKline Biologicals S.A.

Address:

Rue de l'Institut, 89, 1330 Rixensart, Belgium (BE)

Inventor

1

Name:

BLAIS, Normand

Address:

Canada (CA)

2

Name:

GOFFIN, Philippe

Address:

Belgium (BE)

3

Name:

DEWERCHIN, Marianne

Address:

Belgium (BE)

4

Name:

MARTIN, Denis

Address:

Canada (CA)

5

Name:

DEHOTTAY, Philippe Marc Helene

Address:

Belgium (BE)

Priority

Priority Number:

0917647

Priority Date:

08/10/2009

Priority Country:

United Kingdom (GB)

Classification

IPC classification:

C07K 14/34; C12N 15/62;

Publication

European Patent Bulletin

1

Issue number:

202348

Publication date:

29/11/2023

Description:

Grant (B1)

2

Issue number:

202441

Publication date:

09/10/2024

Description:

Opposition procedure started

Annual Fees

Annual Fee Due Date:

30/04/2025

Annual Fee Number:

15

Annual Fee Amount:

213 Euro

Penalty Fee Amount:

20 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages